Arthur M. Cohen & Associates’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.88M | Hold |
7,470
| – | – | 0.29% | 48 |
|
|
2026
Q1 | $1.61M | Hold |
7,470
| – | – | 0.29% | 47 |
|
|
2025
Q4 | $1.71M | Sell |
7,470
-90
| -1% | -$20.5K | 0.28% | 47 |
|
|
2025
Q3 | $1.75M | Buy |
7,560
+20
| +0.3% | +$4.07K | 0.29% | 48 |
|
|
2025
Q2 | $1.4M | Hold |
7,540
| – | – | 0.25% | 52 |
|
|
2025
Q1 | $1.58M | Sell |
7,540
-453
| -6% | -$88.1K | 0.3% | 43 |
|
|
2024
Q4 | $1.42M | Sell |
7,993
-369
| -4% | -$67.8K | 0.25% | 52 |
|
|
2024
Q3 | $1.65M | Hold |
8,362
| – | – | 0.3% | 44 |
|
|
2024
Q2 | $1.43M | Sell |
8,362
-55
| -0.7% | -$9.11K | 0.26% | 50 |
|
|
2024
Q1 | $1.53M | Sell |
8,417
-420
| -5% | -$72.4K | 0.32% | 43 |
|
|
2023
Q4 | $1.37M | Buy |
8,837
+170
| +2% | +$24.8K | 0.32% | 47 |
|
|
2023
Q3 | $1.29M | Buy |
8,667
+50
| +0.6% | +$7.34K | 0.33% | 47 |
|
|
2023
Q2 | $1.16M | Hold |
8,617
| – | – | 0.29% | 52 |
|
|
2023
Q1 | $1.37M | Buy |
8,617
+1,005
| +13% | +$154K | 0.37% | 41 |
|
|
2022
Q4 | $1.23M | Buy |
7,612
+970
| +15% | +$149K | 0.34% | 46 |
|
|
2022
Q3 | $891K | Buy |
6,642
+1,322
| +25% | +$190K | 0.24% | 56 |
|
|
2022
Q2 | $815K | Buy |
5,320
+200
| +4% | +$30.6K | 0.2% | 61 |
|
|
2022
Q1 | $830K | Sell |
5,120
-110
| -2% | -$16K | 0.18% | 68 |
|
|
2021
Q4 | $720K | Hold |
5,230
| – | – | 0.13% | 83 |
|
|
2021
Q3 | $574K | Sell |
5,230
-254,422
| -98% | -$29.1M | 0.12% | 94 |
|
|
2021
Q2 | $599K | Buy |
259,652
+254,422
| +4,865% | +$28.7M | 0.12% | 97 |
|
|
2021
Q1 | $566K | Buy |
5,230
+200
| +4% | +$21.4K | 0.13% | 94 |
|
|
2020
Q4 | $539K | Hold |
5,030
| – | – | 0.13% | 94 |
|
|
2020
Q3 | $441K | Hold |
5,030
| – | – | 0.11% | 96 |
|
|
2020
Q2 | $494K | Hold |
5,030
| – | – | 0.15% | 79 |
|
|
2020
Q1 | $369K | Buy |
5,030
+490
| +11% | +$41.7K | 0.15% | 77 |
|
|
2019
Q4 | $402K | Sell |
4,540
-1,260
| -22% | -$105K | 0.12% | 88 |
|
|
2019
Q3 | $439K | Sell |
5,800
-262
| -4% | -$18K | 0.12% | 82 |
|
|
2019
Q2 | $448K | Sell |
6,062
-790
| -12% | -$62.1K | 0.15% | 78 |
|
|
2019
Q1 | $552K | Buy |
6,852
+200
| +3% | +$16.4K | 0.2% | 63 |
|
|
2018
Q4 | $630K | Hold |
6,652
| – | – | 0.2% | 65 |
|
|
2018
Q3 | $630K | Buy |
6,652
+10
| +0.2% | +$948 | 0.19% | 66 |
|
|
2018
Q2 | $647K | Sell |
6,642
-10
| -0.2% | -$977 | 0.24% | 60 |
|
|
2018
Q1 | $607K | Buy |
6,652
+6,022
| +956% | +$662K | 0.23% | 63 |
|
|
2017
Q4 | $630K | Buy |
+630
| New | +$59.4K | 0.17% | 62 |
|
|
2017
Q2 | $476K | Buy |
6,562
+340
| +5% | +$22.9K | 0.19% | 73 |
|
|
2017
Q1 | $405K | Buy |
+6,222
| New | +$391K | 0.18% | 68 |
|
|
2014
Q3 | $614K | Buy |
+6,902
| New | +$383K | 0.29% | 63 |
|
Other funds holding ABBV
Arthur M. Cohen & Associates's ABBV Position: Q2 2026 in Review
Arthur M. Cohen & Associates held its AbbVie (ABBV) position steady in Q2 2026 at 7,470 shares worth $1.88M. The position accounts for 0.29% of the portfolio, ranked #48.
Arthur M. Cohen & Associates first reported a position in ABBV in Q3 2014 and has held it in 38 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Arthur M. Cohen & Associates held 7,470 shares of AbbVie worth $1.88M as of Q2 2026.
- Arthur M. Cohen & Associates left its AbbVie share count unchanged in Q2 2026.
- AbbVie made up 0.29% of Arthur M. Cohen & Associates's portfolio in Q2 2026, its #48 holding.
- Arthur M. Cohen & Associates first reported a position in AbbVie in Q3 2014 and has held it in 38 quarters since.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Arthur M. Cohen & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.